Consequently, inhibitors of the integrated stress response, such as ISRIB, and other small molecules that target the endoplasmic reticulum stress response, hold promise as potential therapeutic strategies for addressing C9orf72 ALS/FTD. The gene discussed is C9orf72; the disease is frontotemporal dementia.